# Processa Pharmaceuticals, Inc.: Form 8-K, filed Jun 18, 2025

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2025-06-18
- Accepted by EDGAR: Jun 18, 2025, 17:29 ET
- Period: 2025-06-17
- Accession: 0001641172-25-015654
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000164117225015654/form8-k.htm

Filed Jun 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-015654. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.